You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 6, 2025

Drug Price Trends for NDC 64380-0170


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 64380-0170

Drug Name NDC Price/Unit ($) Unit Date
IMIPRAMINE HCL 25 MG TABLET 64380-0170-01 0.08202 EACH 2024-12-18
IMIPRAMINE HCL 25 MG TABLET 64380-0170-02 0.08202 EACH 2024-12-18
IMIPRAMINE HCL 25 MG TABLET 64380-0170-01 0.07455 EACH 2024-11-20
IMIPRAMINE HCL 25 MG TABLET 64380-0170-02 0.07455 EACH 2024-11-20
IMIPRAMINE HCL 25 MG TABLET 64380-0170-02 0.08800 EACH 2024-10-23
IMIPRAMINE HCL 25 MG TABLET 64380-0170-01 0.08800 EACH 2024-10-23
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for NDC 64380-0170

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
IMIPRAMINE HCL 25MG TAB Golden State Medical Supply, Inc. 64380-0170-01 100 5.39 0.05390 2024-01-01 - 2028-06-14 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

64380-0170 Market Analysis and Financial Projection

Market Analysis and Price Projections for Drug NDC: 64380-0170

Introduction

The drug with the National Drug Code (NDC) 64380-0170 is a formulation of Testosterone Gel 1%, a topical medication used to treat hypogonadism in men. Here, we will delve into the market analysis and price projections for this drug, considering various factors such as market trends, regulatory environments, and economic influences.

Market Context

Specialty Pharmaceuticals

The pharmaceutical market, particularly the segment of specialty pharmaceuticals, is experiencing significant growth. According to Vizient, Inc., drug price inflation is projected to increase by 3.8% in 2024, driven partly by the increasing utilization of specialty pharmacy products, including those for chronic and complex conditions[2].

Drug Specifics

Testosterone Gel 1%

Testosterone Gel 1% is classified as a Schedule III controlled substance and is contraindicated in men with carcinoma of the breast or known or suspected carcinoma of the prostate[1].

Price Trends

General Pharmaceutical Price Increases

Recent data indicates that prescription drug prices have been rising steadily. From January 2022 to January 2023, more than 4,200 drug products experienced price increases, with an average increase of 15.2% or $590 per drug product. This trend suggests that prices for existing drugs, including testosterone gel, may continue to rise[5].

Specialty Drug Pricing

Specialty pharmaceuticals, which include drugs for chronic and complex conditions, tend to have higher price increases. While the percentage increases for multi-source drugs are higher, the absolute dollar increases are typically larger for single-source drugs. Given that testosterone gel is a specialty product, it may follow similar pricing trends[5].

Regulatory Environment

FDA Regulations and NDC Directory

The FDA maintains the National Drug Code (NDC) Directory, which includes prescription drugs, OTC drugs, and insulin products. The NDC for Testosterone Gel 1% (64380-0170) is part of this directory, ensuring compliance with FDA regulations. Any changes in the regulatory landscape, such as updates to the Drug Listing Act, could impact pricing and availability[4].

Market Projections

Demand and Supply Dynamics

The demand for testosterone replacement therapies is relatively stable, driven by the prevalence of hypogonadism. However, the supply chain and manufacturing costs can influence pricing. With the projected increase in drug prices overall, it is likely that the price of Testosterone Gel 1% will also rise.

Competitive Landscape

The market for testosterone replacement therapies is competitive, with several products available. However, the specific formulation and brand (in this case, Strides Pharma Science Limited) can influence pricing based on market share and consumer preference.

Economic Factors

Healthcare Expenditure and Reimbursement

Healthcare austerity measures and changing reimbursement landscapes can impact the pricing of pharmaceuticals. As healthcare providers and payers become more cost-conscious, pharmaceutical companies may need to adjust their pricing strategies to ensure reimbursement approval[3].

Price Projections

Given the current trends and factors:

  • Short-term Projections: The price of Testosterone Gel 1% is likely to increase in line with the overall pharmaceutical market trend, potentially by 3-5% annually.
  • Long-term Projections: Over the next few years, the price could rise more significantly, driven by the increasing costs of specialty pharmaceuticals and the general inflation in the healthcare sector.

Key Takeaways

  • The price of Testosterone Gel 1% is expected to rise due to overall pharmaceutical market trends.
  • Specialty pharmaceuticals, including testosterone gel, are experiencing higher price increases.
  • Regulatory and economic factors, such as FDA regulations and healthcare expenditure, will influence pricing.
  • The competitive landscape and demand for testosterone replacement therapies will also play a role in price projections.

FAQs

What is the current NDC for Testosterone Gel 1%?

The NDC for Testosterone Gel 1% is 64380-0170.

Why are drug prices increasing?

Drug prices are increasing due to various factors, including the rising costs of specialty pharmaceuticals, general inflation in the healthcare sector, and changes in regulatory and reimbursement landscapes[2][5].

How does the FDA regulate drug pricing?

The FDA does not directly regulate drug pricing but ensures compliance with regulations such as the Drug Listing Act. Pricing is influenced by market dynamics and regulatory approvals[4].

What are the potential impacts of healthcare austerity measures on drug pricing?

Healthcare austerity measures can lead to increased cost-consciousness among healthcare providers and payers, potentially limiting premium pricing opportunities for pharmaceutical companies[3].

How competitive is the market for testosterone replacement therapies?

The market for testosterone replacement therapies is competitive, with several products available. This competition can influence pricing based on market share and consumer preference.

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.